Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised … JP Neoptolemos, DH Palmer, P Ghaneh, EE Psarelli, JW Valle, ... The Lancet 389 (10073), 1011-1024, 2017 | 1880 | 2017 |
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study JW Valle, D Palmer, R Jackson, T Cox, JP Neoptolemos, P Ghaneh, ... Journal of clinical oncology 32 (6), 504-512, 2014 | 451 | 2014 |
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial W Greenhalf, P Ghaneh, JP Neoptolemos, DH Palmer, TF Cox, RF Lamb, ... Journal of the National Cancer Institute 106 (1), djt347, 2014 | 295 | 2014 |
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of … AR Pettitt, R Jackson, S Carruthers, J Dodd, S Dodd, M Oates, ... Journal of Clinical Oncology 30 (14), 1647-1655, 2012 | 238 | 2012 |
Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases RP Jones, R Jackson, DFJ Dunne, HZ Malik, SW Fenwick, GJ Poston, ... Journal of British Surgery 99 (4), 477-486, 2012 | 227 | 2012 |
The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma P Ghaneh, J Kleeff, CM Halloran, M Raraty, R Jackson, J Melling, O Jones, ... Annals of surgery 269 (3), 520-529, 2019 | 223 | 2019 |
Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial A Sharp, C Cornforth, R Jackson, J Harrold, MA Turner, LC Kenny, ... The Lancet Child & Adolescent Health 2 (2), 93-102, 2018 | 222 | 2018 |
Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial RP Jones, EE Psarelli, R Jackson, P Ghaneh, CM Halloran, DH Palmer, ... JAMA surgery 154 (11), 1038-1048, 2019 | 182 | 2019 |
Effect of specialist decision-making on treatment strategies for colorectal liver metastases RP Jones, JN Vauthey, R Adam, M Rees, D Berry, R Jackson, N Grimes, ... Journal of British Surgery 99 (9), 1263-1269, 2012 | 167 | 2012 |
Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: a meta-analysis of randomized phase III trials R Jackson, EE Psarelli, S Berhane, H Khan, P Johnson Journal of Clinical Oncology 35 (6), 622-628, 2017 | 159 | 2017 |
Chemotherapy and radiotherapy for advanced pancreatic cancer V Chin, A Nagrial, K Sjoquist, CA O'Connor, L Chantrill, AV Biankin, ... Cochrane Database of Systematic Reviews, 2018 | 147 | 2018 |
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic … P Ghaneh, D Palmer, S Cicconi, R Jackson, CM Halloran, C Rawcliffe, ... The Lancet Gastroenterology & Hepatology 8 (2), 157-168, 2023 | 112 | 2023 |
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomized controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible … RJ Shaw, CJ Butterworth, P Silcocks, BT Tesfaye, M Bickerstaff, ... International Journal of Radiation Oncology* Biology* Physics 104 (3), 530-539, 2019 | 101 | 2019 |
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer K Takaori, C Bassi, A Biankin, TB Brunner, I Cataldo, F Campbell, ... Pancreatology 16 (1), 14-27, 2016 | 101 | 2016 |
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre … G Middleton, DH Palmer, W Greenhalf, P Ghaneh, R Jackson, T Cox, ... The Lancet Oncology 18 (4), 486-499, 2017 | 72 | 2017 |
European Study Group for Pancreatic Cancer. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC … JP Neoptolemos, DH Palmer, P Ghaneh, EE Psarelli, JW Valle, ... Lancet 389 (10073), 1011-1024, 2017 | 66 | 2017 |
The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer M Thornton, MA Aslam, EM Tweedle, C Ang, F Campbell, R Jackson, ... International journal of cancer 133 (6), 1408-1418, 2013 | 66 | 2013 |
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer J Kleeff, E Costello, R Jackson, C Halloran, W Greenhalf, P Ghaneh, ... British journal of cancer 115 (7), 887-894, 2016 | 61 | 2016 |
Head and neck cancer surgery during the COVID‐19 pandemic: an international, multicenter, observational cohort study COVIDSurg Collaborative, R Shaw, SC Winter, J Glasbey, MWS Ho, ... Cancer 127 (14), 2476-2488, 2021 | 60 | 2021 |
Diagnostic accuracy of individual antenatal tools for prediction of small‐for‐gestational age at birth B Poljak, U Agarwal, R Jackson, Z Alfirevic, A Sharp Ultrasound in Obstetrics & Gynecology 49 (4), 493-499, 2017 | 49 | 2017 |